These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6209243)

  • 21. [Early detection of prostatic carcinoma: Is PSA screening suitable?].
    Kaulen H
    Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
    Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
    Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contribution of immunohistology in the differential diagnosis of tumor pathology].
    von Overbeck J; Lautenschlager C; Mihatsch M; Stähli C; Gudat F; Heitz PU
    Helv Chir Acta; 1985 Sep; 52(3-4):455-7. PubMed ID: 2415481
    [No Abstract]   [Full Text] [Related]  

  • 24. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.
    Maygarden SJ
    Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385
    [No Abstract]   [Full Text] [Related]  

  • 25. Urologic evaluation of atypical prostatic hyperplasia.
    Garnett JE; Oyasu R
    Urology; 1989 Dec; 34(6 Suppl):66-9. PubMed ID: 2481365
    [No Abstract]   [Full Text] [Related]  

  • 26. The evaluation and treatment of BPH, 2002.
    Stein B
    Med Health R I; 2002 May; 85(5):153-5. PubMed ID: 12048748
    [No Abstract]   [Full Text] [Related]  

  • 27. Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies.
    Hosler GA; Epstein JI
    Hum Pathol; 2005 May; 36(5):480-5. PubMed ID: 15948114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of prostate carcinoma on biopsy specimens improved by basal-cell-specific anti-cytokeratin antibody (34 beta E12).
    Freibauer C
    Wien Klin Wochenschr; 1998 Sep; 110(17):608-11. PubMed ID: 9816630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic problems in prostatic pathology: microglandular lesions and intraductal epithelial proliferations].
    Berger N; Borda A
    Arch Anat Cytol Pathol; 1996; 44(4):141-59. PubMed ID: 9157823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?
    Izawa JI; Lega I; Downey D; Chin JL; Luke PP
    BJU Int; 2005 Aug; 96(3):320-3. PubMed ID: 16042722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of cancer in hyperplastic nodes of the prostate.
    Bialik VV
    Arkh Patol; 1974; 36(2):68-70. PubMed ID: 4141613
    [No Abstract]   [Full Text] [Related]  

  • 32. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
    Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between dysplastic lesions and latent cancers of the prostate. An analysis of 100 autopsies].
    Schütze U
    Z Urol Nephrol; 1984 Sep; 77(9):529-35. PubMed ID: 6209871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Allergic vasculitis in benign prostatic hyperplasia combined with a latent prostatic carcinoma].
    Shmurun RI
    Urol Nefrol (Mosk); 1997; (5):46-9. PubMed ID: 9412017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psagraph: a simple graphical and useful tool for follow-up and decision on biopsy and treatment of patients with prostatic diseases.
    Dawam D; Bhatt T; Kourieffs C; Naseem M; Masood S; Sheriff M; Palmer JH
    BJU Int; 2007 May; 99(5):1169. PubMed ID: 17437449
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transrectal biopsy of the prostate with a cutting needle].
    Reziciner S
    J Urol Nephrol (Paris); 1977; 83(1-2):85-7. PubMed ID: 69039
    [No Abstract]   [Full Text] [Related]  

  • 39. Franzen-positive carcinoma of the prostate in histologically benign glands.
    Swift AC; Slade N; Gingell JC
    Cancer Detect Prev; 1982; 5(2):195-200. PubMed ID: 6181875
    [No Abstract]   [Full Text] [Related]  

  • 40. [Suspicious acinar proliferations of the prostate].
    Helpap B
    Verh Dtsch Ges Pathol; 1999; 83():162-7. PubMed ID: 10714207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.